Category: Cancer detection
-
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more -
Isabel Esain Garcia awarded PhD Thesis Prize
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
World first trial to revolutionise treatment of brain cancer
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more -
Institute receives unprecedented £173M commitment from CRUK
Cancer Research UK has announced a £173 million investment in the Cambridge Institute - the largest single grant ever awarded by the charity outside of London.
Find out more -
Madzia Crossley appointed as Junior Group Leader
Dr Magdalena (Madzia) Crossley will be joining the Cancer Research UK Cambridge Institute as a Junior Group Leader starting in early 2025.
Find out more -
Cambridge children’s cancer scientists to share £3M boost
Cambridge researchers are set to receive a major cash injection from Cancer Research UK to help develop the next generation of treatments for children with brain tumours.
Find out more -
Scientists awarded £5m to advance groundbreaking tumour mapping technology
The IMAXT team have been awarded £5.2 million to establish the Spatial Profiling and Annotation Centre of Excellence (SPACE) to open up access to their groundbreaking cancer mapping technology to the research field.
Find out more -
Maike de la Roche secures funding to develop new immunotherapy targeting colorectal and liver cancers
Scientists at the University of Cambridge have developed a potential new immunotherapy treatment that targets a protein found in colorectal and liver cancers.
Find out more -
Quest for Cures: Glioblastoma research receives £1.5 million from The Brain Tumour Charity
The Creixell Group has been awarded a £1.5 million ‘Quest for Cures’ grant from The Brain Tumour Charity for research aimed at improving treatments for glioblastoma.
Find out more